F-18 labelled PSMA-1007: biodistribution, radiation …
18 F-PSMA-1007 was selected among several 18 F-PSMA-ligand candidate compounds because it demonstrated high labelling yields, outstanding tumor …
- Author: Frederik L. Giesel, B. Hadaschik, J. Cardinale, J. Radtke, M. Vinsensia, W. Lehnert, C. Kesch, Y. To...
- Publish Year: 2017
Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with ...
18 F-PSMA-1007 is a novel PSMA ligand that has excellent preclinical characteristics and that is only minimally excreted by the urinary tract, a potential advantage for pelvic imaging. The aim …
Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA …
18 F-PSMA-1007 is a novel prostate-specific membrane antigen (PSMA)-based radiopharmaceutical for imaging prostate cancer (PCa). The aim of this study was to compare …
- Studies of Psma-1007
Parameters predicting [18F]PSMA-1007 scan positivity and type …
Apr 30, 2021 · [18 F]PSMA-1007-PET/CT showed a high positivity rate in patients with biochemically recurrent PCa. PSA value and PSA velocity were significant predictors of scan …
- Author: Niloefar Ahmadi Bidakhvidi, Annouschka Laenen, Sander Jentjens, Christophe M. Deroose, Koen Van Laer...
- DOI: 10.1186/s13550-021-00783-w
- Publish Year: 2021
- Publication: EJNMMI Res. 2021; 11: 41.
Preclinical Evaluation of 18F-PSMA-1007, a New Prostate-Specific ...
Therefore, we recommend clinical transfer of the radioligand 18 F-PSMA-1007 for use as a diagnostic PET tracer in prestaging and monitoring of prostate cancer. Keywords: 18F; PET; …
Fluorine-18 labelled prostate-specific membrane antigen (PSMA) …
Dec 1, 2020 · Fluorine-18 PSMA-1007 is a novel PET-CT radiotracer. It can be used to localise sites of recurrent prostate cancer. It may also be used in the staging of high risk prostate …
- Author: R.W. Foley, S.L. Redman, R.N. Graham, W.W. Loughborough, D. Little
- Publish Year: 2020
fluorine F 18 PSMA-1007 - National Cancer Institute
A radioconjugate containing the human prostate-specific membrane antigen (PSMA)-targeting ligand, PSMA-1007, labeled with the radioisotope fluorine F 18, with potential imaging activity …
Comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 PET/CT …
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) hybrid imaging can help improve the diagnosis of recurrent PC, in addition to conventional methods such as …
PSMA-1007 | PSMA Ligand - MedChemExpress
PSMA-1007 is a prostate-specific membrane antigen (PSMA) ligand. 18F-labeled PSMA-1007 can be used as a PET tracer for prostate cancer imaging. PSMA-1007 can be used for the …
Dose-reduced [18F]PSMA-1007 PET is feasible for functional …
Oct 29, 2021 · Renal [18 F]PSMA-1007 PET-CT is feasible, with imaging 2 h p.i., acceptable split renal uptake variability, and effective dose and acquisition time comparable to those of [99m …
